What smart money is saying about Elanco Animal Health Incorporated
2 funds in our archive have pitched Elanco Animal Health Incorporated, most recently Baron Health Care Fund in December 2025.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Get an email when a fund buys, sells or pitches it
Position history
Between Q4 2025 and Q3 2026, 5 fund letters reported a position in Elanco Animal Health Incorporated, with 2 sells (trimmed or exited).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 2 | 0 |
| Q1 2026 | 1 | 0 | 0 | 0 |
| Q4 2025 | 0 | 0 | 0 | 2 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 5 positions · 2 moves
- September 2026
“In addition to the transactions discussed above, we initiated a new position in Danaher in the health care sector. We exited positions in Thermo Fisher Scientific, Gilead Sciences and Elanco Animal Health in the health care sector, Broadcom in the IT sector, Nestle and Celsius in the consumer staples sector, GXO Logistics and WESCO International in the industrials sector and Teck Resources in the materials sector.”
Elanco Animal Health Incorporated - September 2026
“Elanco Animal Health, Inc.”
Elanco Animal Health Incorporated - September 2026
“Innovative animal health solutions provider Elanco Animal Health Incorporated also detracted, as investors became concerned about a price war with Zoetis which has been losing market share to Elanco. We remain shareholders, as we believe concerns about a price war are overblown, and we remain encouraged by the company's market share gains, margin improvement, and continued deleveraging.”
Elanco Animal Health Incorporated - September 2026
“Elanco Animal Health (ELAN) is an animal health company. We divested our position as relative strength deteriorated tied to industry-wide demand concerns and fears of rising competition.”
Elanco Animal Health Incorporated - March 2026
Listed in HL Global Small Companies Equity’s reported holdings.
Elanco Animal Health Incorporated
Fund coverage · 2 theses
- Baron Health Care FundDecember 2025
Elanco Animal Health Incorporated is at an inflection with an accelerating innovation portfolio driving growth, margin expansion, and deleveraging.
Read the full thesis - Hardman Johnston Global EquityDecember 2025
Elanco Animal Health, Inc. is shifting toward higher-margin companion animals with multiple potential blockbusters and deleveraging supporting a strategic turnaround.
Read the full thesis
Read every full thesis on Elanco Animal Health Incorporated
Read all 2 theses in full, with each fund's reasoning, and get unlimited access to the archive.
View plans→